Fischer Medical Ventures Ltd

Fischer Medical Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Fischer Medical Ventures Ltd

₹ 39.3 1.13%
03 Jul - close price
fischermv.com BSE: 524743 NSE: FISCHER
About

Incorporated in 1993, Fischer Chemic Ltd does trading of chemicals and machineries[1]

Key Points

Business Overview:[1]
Company is in the business of processing, manufacturing and trading of Laboratory Grade Chemicals

Website BSE NSE
  • Market Cap ₹ 2,572 Cr.
  • Current Price ₹ 39.3
  • High / Low ₹ 125 / 31.0
  • Stock P/E
  • Book Value ₹ 5.17
  • Dividend Yield 0.01 %
  • ROCE -1.58 %
  • ROE -3.09 %
  • Face Value ₹ 1.00
Edit ratios

Pros

Cons

  • Stock is trading at 7.61 times its book value
  • Company has low interest coverage ratio.
  • Company has a low return on equity of -1.60% over last 3 years.
  • Company has high debtors of 435 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Equipment & Supplies Medical Equipment & Supplies

Part of BSE Healthcare BSE 1000

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
0.18 0.00 0.19 0.00 11.34 0.00 0.00 0.00 5.22 4.54 7.43 1.32 4.11
0.04 0.10 0.04 0.14 11.43 0.11 0.36 0.22 6.78 4.16 6.28 2.64 13.00
Operating Profit 0.14 -0.10 0.15 -0.14 -0.09 -0.11 -0.36 -0.22 -1.56 0.38 1.15 -1.32 -8.89
OPM % 77.78% 78.95% -0.79% -29.89% 8.37% 15.48% -100.00% -216.30%
0.00 0.00 0.01 0.01 0.72 1.12 0.82 0.87 0.65 0.80 1.43 0.86 0.43
Interest 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.12 1.31 1.12 0.96 1.27
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.03 0.10 0.08 0.08 0.08 0.43
Profit before tax 0.13 -0.11 0.16 -0.13 0.63 1.01 0.46 0.62 -1.13 -0.21 1.38 -1.50 -10.16
Tax % 7.69% 100.00% 6.25% 0.00% 4.76% 16.83% -10.87% 67.74% -21.24% 185.71% 39.13% 11.33% -11.71%
0.12 -0.22 0.14 -0.13 0.60 0.84 0.51 0.20 -0.89 -0.61 0.84 -1.67 -8.98
EPS in Rs 0.71 -0.09 0.06 -0.05 0.01 0.02 0.01 0.00 -0.01 -0.01 0.01 -0.03 -0.14
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
0 0 0 -0 -0 0 0 0 0 12 5 17
0 0 0 0 0 0 0 0 0 12 7 26
Operating Profit -0 -0 -0 -0 -0 -0 -0 -0 0 -0 -2 -9
OPM % -300% -11% -12% 11% -2% -43% -50%
0 0 0 0 0 0 0 0 0 1 3 3
Interest 0 0 0 0 0 0 0 0 0 0 0 5
Depreciation 0 0 0 0 0 0 0 0 0 0 0 1
Profit before tax 0 -0 -0 0 0 -0 -0 -0 0 1 1 -11
Tax % 0% 0% 0% 0% 0% -450% 20% 26% 30% -1%
0 -0 -0 0 0 -0 0 -0 -0 0 1 -10
EPS in Rs 0.01 -0.01 -0.02 0.00 0.00 -0.24 0.82 -1.35 -0.24 0.01 0.01 -0.16
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 48% -31%
Compounded Sales Growth
10 Years: %
5 Years: 152%
3 Years: 359%
TTM: 233%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -1679%
Stock Price CAGR
10 Years: 70%
5 Years: 70%
3 Years: 48%
1 Year: -53%
Return on Equity
10 Years: %
5 Years: %
3 Years: -2%
Last Year: -3%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 3 3 3 0.17 0.17 0.17 0.17 0.17 0.17 54 64 65
Reserves -3 -3 -4 -0 -0 -0 -0 -0 -0 26 272 273
0 0 0 0 0 0 0 0 1 0 22 46
0 0 0 0 0 0 0 0 0 12 1 4
Total Liabilities 0 0 0 0 0 0 0 0 0 92 358 388
0 0 0 0 0 0 0 0 0 0 1 11
CWIP 0 0 0 0 0 0 0 0 0 0 0 0
Investments 0 0 0 0 0 0 0 0 0 41 294 304
0 0 0 0 0 0 0 0 0 51 63 73
Total Assets 0 0 0 0 0 0 0 0 0 92 358 388

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
0 -0 -0 -0 0 0 -0 -0 -0 0 -24 -6
0 0 0 0 0 0 0 0 0 -38 -232 -13
-0 0 0 0 -0 0 0 0 0 38 256 20
Net Cash Flow 0 -0 0 0 -0 0 -0 -0 0 -0 0 1
Free Cash Flow 0 -0 -0 -0 0 0 -0 -0 -0 0 -23 -6
CFO/OP -33% 42% 50% 0% 0% -100% 300% 95% -750% -68% 1,062% 61%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 0 0 0 0 0 345 402 1,194 435
Inventory Days 0 0 0 6 13
Days Payable 31 114
Cash Conversion Cycle 0 0 0 0 0 345 402 1,169 333
Working Capital Days -365 365 365 -41 21 -831 1,215 1,408 348
ROCE % -350% 0% 8% -22% -13% -97% 9% 1% 0% -2%

Insights

In beta
Mar 2024 Mar 2025
International markets served
countries

Log in to view insights

Please log in to see hidden values.

Login
Total employees
employees
Cumulative preventive health screenings delivered
screenings
MOUs signed for PICA MRI systems at RSNA 2024
MOUs
MRI manufacturing capacity (double shift maximum)
MRI machines per year
MRI manufacturing capacity (single shift)
MRI machines per year
Schools in health screening partnership
schools
Target annual preventive health screenings
screenings per year
TB and cancer screenings in Assam
individuals screened

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
0.00% 0.00% 0.00% 0.00% 74.91% 74.91% 74.91% 62.82% 61.80% 61.80% 61.80% 62.15%
0.00% 0.00% 0.00% 5.07% 5.07% 5.07% 5.07% 5.23% 5.55% 5.57% 4.85% 4.97%
0.00% 0.00% 0.00% 1.68% 1.68% 1.68% 1.68% 1.44% 1.42% 1.42% 1.36% 1.38%
99.99% 100.00% 99.99% 93.24% 18.33% 18.33% 18.32% 30.51% 31.23% 31.22% 31.99% 31.51%
No. of Shareholders 9,1009,1049,0388,9769,2859,5029,68810,18010,05813,05422,92023,269

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Concalls